CUREosity
Our approach is to build visionary, intelligent applications and products, through a combination of creativity, neuroscience and technology. We heal, reprogram and enhance the human nervous system.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD23—34m (Dealroom.co estimates Jun 2024.)
Company register number HRB 85411 (Düsseldorf)
Düsseldorf Nordrhein-Westfalen (HQ)
Financials
Estimates*
| EUR | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | - | <1m | <1m | <1m | <1m |
| % growth | - | - | 5835 % | 18 % | 22 % |
| Profit | (<1m) | - | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
* | €1.1m | Seed | |
$3.5m | Seed | ||
* | €3.8m | Early VC | |
| Total Funding | CAD12.1m | ||
Related Content
Recent News about CUREosity
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.